Sign In
Buy LMNX
$7.67
-0.132 (-1.70%)
At Close: Jul 31, 2026
Shareholder Alert: Ademi LLP investigates whether Luminex Corporation has obtained a Fair Price in its transaction with DiaSorin
11:35am, Monday, 12'th Apr 2021
MILWAUKEE, April 12, 2021 /PRNewswire/ -- Ademi LLP is investigating Luminex (NASDAQ: LMNX) for possible breaches of fiduciary duty and other violations of law in its transaction with DiaSorin. Click
LMNX Stock: Over 9% Increase Pre-Market Explanation
06:17am, Monday, 12'th Apr 2021
The stock price of Luminex Corporation (NASDAQ: LMNX) increased by over 9% pre-market. This is why it happened.
DiaSorin to acquire U.S.-based Luminex for around $1.8 billion
03:47am, Monday, 12'th Apr 2021
Shares of Italian diagnostic specialist DiaSorin surged 7% on Monday after announcing a deal to buy COVID-19 testing kit maker Luminex Corp. for around $1.8 billion. DiaSorin will pay $37 for each sha
Here's Why You Should Retain Luminex (LMNX) Stock for Now
12:54pm, Tuesday, 06'th Apr 2021
Investor confidence is high in Luminex (LMNX) stock, courtesy of its solid prospects.
Olink Holding Pursues $300 Million U.S. IPO Effort
03:42pm, Monday, 22'nd Mar 2021
Olink Holding AB has filed to raise $300 million in a U.S. IPO.
Luminex (LMNX) Files EUA Application for New Respiratory Assay
01:59pm, Monday, 15'th Mar 2021
Luminex (LMNX) develops the combined assay to rapidly deliver clear solutions about respiratory infections from a single test.
Luminex (LMNX) Up 14.4% Since Last Earnings Report: Can It Continue?
12:08pm, Wednesday, 10'th Mar 2021
Luminex (LMNX) reported earnings 30 days ago. What's next for the stock?
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
06:30am, Wednesday, 10'th Mar 2021
AUSTIN, Texas, March 10, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an Emergency Use Authorization application to the U.S. Food and Drug Administrat
Luminex (LMNX) Surges 6.3%: Is This an Indication of Further Gains?
07:36am, Thursday, 04'th Mar 2021
Luminex (LMNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2
06:30am, Thursday, 04'th Mar 2021
AUSTIN, Texas, March 4, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)
Here's Why You Should Retain Luminex (LMNX) Stock for Now
10:37am, Tuesday, 02'nd Mar 2021
Investor confidence is high in Luminex (LMNX) stock, courtesy of its solid prospects.
Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel
06:30am, Friday, 19'th Feb 2021
AUSTIN, Texas, Feb. 19, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received $11.3 million in funding from the Biomedical Advanced Research and Development Auth
Luminex Corporation (LMNX) CEO Homi Shamir on Q4 2020 Results - Earnings Call Transcript
10:49pm, Monday, 08'th Feb 2021
Luminex Corporation (LMNX) CEO Homi Shamir on Q4 2020 Results - Earnings Call Transcript
Luminex (LMNX) Q4 Earnings Miss Estimates
06:12pm, Monday, 08'th Feb 2021
Luminex (LMNX) delivered earnings and revenue surprises of -92.86% and 0.35%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Luminex Corporation Declares First Quarter Cash Dividend
01:00pm, Monday, 08'th Feb 2021
AUSTIN, Texas, Feb. 8, 2021 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the first quarter of 2021 of $0.1
